Robert Kleinman

Dr. Kleinman is a clinician-scientist and Assistant Professor in the Department of Psychiatry. He completed his medical degree at Queen’s University, psychiatry residency at Stanford, and fellowship in addiction psychiatry at Mass General Brigham (Harvard). He provides treatment to patients experiencing substance use disorders, behavioral addictions, and concurrent disorders at the Centre for Addiction and Mental Health. 

His research is focused on improving access to evidence-based treatments for substance use disorders and has three main foci: 1) examining regulatory, transportation, and geography-based barriers to treatment; 2) appraisal of treatments that impact the care of individuals experiencing substance use disorders; and 3) identifying modifiable risk factors for complications of substance use disorders.

Recent Publications

1.    Kleinman RA and Schatzberg AF. Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids. American Journal of Psychiatry. 2021;178(3):221-223.
2.    Kleinman RA. Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US. JAMA Psychiatry. JAMA Psychiatry. 2020;77(11):1163-1171. 
3.    Kleinman RA and Morris NP. Is it Time to Reschedule Heroin? JAMA Psychiatry. 2020;77(8):781-782.  
4.    Morris NP and Kleinman RA. Opioid Reversals Save Lives-Period. JAMA Psychiatry. 2020;77(4):339-340.
5.    Morris NP and Kleinman RA. Involuntary Commitments: Billing Patients for Forced Psychiatric Treatment. American Journal of Psychiatry. 2020;177(12):1115-1116.